Works matching IS 00126667 AND DT 2025 AND VI 85 AND IP 5


Results: 11
    1
    2
    3
    4
    5
    6

    The Tailored Biosimilar Approach: Expectations and Requirements.

    Published in:
    Drugs, 2025, v. 85, n. 5, p. 601, doi. 10.1007/s40265-025-02168-y
    By:
    • Guillen, Elena;
    • Barry, Sean;
    • Jost, Nils;
    • Ekman, Niklas;
    • Knippel, Verena;
    • Kuhlmann-Gottke, Johanna;
    • Maier, Julia;
    • Weise, Martina;
    • Laslop, Andrea;
    • Anour, René;
    • van Zandbergen, Ger;
    • Kirsch‑Stefan, Nadine
    Publication type:
    Article
    7
    8

    Cosibelimab: First Approval.

    Published in:
    Drugs, 2025, v. 85, n. 5, p. 695, doi. 10.1007/s40265-025-02164-2
    By:
    • Lee, Arnold
    Publication type:
    Article
    9

    Zanidatamab: First Approval.

    Published in:
    Drugs, 2025, v. 85, n. 5, p. 707, doi. 10.1007/s40265-025-02163-3
    By:
    • Keam, Susan J.
    Publication type:
    Article
    10
    11

    Stapokibart: First Approval.

    Published in:
    Drugs, 2025, v. 85, n. 5, p. 715, doi. 10.1007/s40265-025-02151-7
    By:
    • Shirley, Matt
    Publication type:
    Article